890900 | ALC-0315
6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium
ALC-0315
6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium
ALC-0315 is an ionizable cationic lipid used in combination with other lipids to form lipid nanoparticles (LNPs).
C48H96NO5
C 75.24%, H 12.50%, N 1.83%, O 10.44%
- ChemDraw File
- Structure
- Safety Data Sheet
Schoenmaker, Linde et al. “mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.” International journal of pharmaceutics vol. 601 (2021): 120586. doi:10.1016/j.ijpharm.2021.120586
PubMed ID: 33839230- Certificate of Analysis(Lot No. 890900O-1G-A-010and 7049OQA010)
- Certificate of Analysis(Lot No. 890900O-200MG-A-010and 7049ONA010)
- Certificate of Analysis(Lot No. 890900O-1G-B-010and 7049OQB010)
- Certificate of Analysis(Lot No. 890900O-100MG-B-010and 7049OLB010)
- Certificate of Analysis(Lot No. 890900O-50MG-B-010and 7049OKB010)
- Certificate of Analysis(Lot No. 890900O-100MG-A-010and 7049OLA010)
- Certificate of Analysis(Lot No. 890900O-25MG-A-010and 7049OJA010)
- Certificate of Analysis(Lot No. 890900O-500MG-A-010and 7049OPA010)